Frostrow Capital

To seek capital appreciation through investment in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.

To achieve capital and income growth and to provide shareholders with a total return in excess of that of the FTSE All-Share Index.

To generate long-term shareholder returns, predominantly in the form of capital growth, by investing in businesses and opportunities, delivering or benefiting from the efficient use of energy and resources.

To achieve long-term capital growth through investment in selected companies in the Asia Pacific region and the Indian Subcontinent, but excluding Japan, Australia and New Zealand (the Asia Pacific Region).

To achieve a high level of capital growth by investing worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.